prednisone has been researched along with arginine in 113 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (30.97) | 18.7374 |
| 1990's | 47 (41.59) | 18.2507 |
| 2000's | 19 (16.81) | 29.6817 |
| 2010's | 11 (9.73) | 24.3611 |
| 2020's | 1 (0.88) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lieberman, J | 1 |
| Balestrieri, GP; Bodini, C; Bossoni, S; Girelli, A; Giustina, A; Pizzocolo, G; Wehrenberg, WB | 1 |
| Bozzola, M; Cisternino, M; Gambarana, D; Giorgiani, G; Locatelli, F; Moretta, A; Severi, F; Valtorta, A | 1 |
| Kogut, MD; Roe, TF | 1 |
| Eisen, V; Greenbaum, L; Lewis, GP | 1 |
| Calcagno, PL; Gaboardi, F; Martin, MM; Podolsky, S; Raiti, S | 1 |
| Ziegler, K | 1 |
| Bhoopalam, N; Robertson, GL; Zelkowitz, LJ | 1 |
| Blum, WF; de Muinck Keizer-Schrama, SM; Drop, SL; Hokken-Koelega, AC; Stijnen, T | 1 |
| Pittelkow, MR; Robertson, RP; Seaquist, ER; Teuscher, AU | 1 |
| Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, J | 1 |
| Robertson, RP; Seaquist, ER; Teuscher, AU | 1 |
| Ah-See, AK; Brittenden, J; Eremin, O; Gilbert, F; Heys, SD; Hutcheon, AW; McKean, M; Miller, I; Needham, G; Sarkar, TK | 1 |
| Alexander, JW; Gennari, R | 1 |
| Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG | 1 |
| Faller, DV; Fingeroth, J; Mentzer, SJ; Perrine, SP; Reilly, JJ | 1 |
| Abdul-Latif, H; Bowers, CY; Culler, FL; Meacham, LR; Sullivan, KM | 1 |
| Becker, M; Bossi, L; Cha, HJ; de la Porte, S; Escolar, DM; Farajian, V; Francia, D; Gernapudi, R; Gordish-Dressman, H; Guerron, AD; Hoffman, EP; Nagaraju, K; Pandey, GS; Partridge, T; Pistilli, E; Rawat, R; Sali, A; Spurney, CF; Zerr, P | 1 |
| Darki, A; Jacobs, W; Kodali, PP; McPheters, JP; Patel, MR; Virk, H | 1 |
| Cvetkovic, TP; Djordjevic, VM; Paunovic, GJ; Pavlovic, DD; Stefanovic, NZ; Stojanovic, DR; Stojanovic, IR; Velickovic-Radovanovic, RM | 1 |
| Buonvicino, D; Chiarugi, A; Muzzi, M; Pistolesi, A; Urru, M | 1 |
| Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M | 1 |
| Sullivan, MP; Sutow, WW | 1 |
| Le Bourgeois, JP | 1 |
| Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J | 1 |
| Brunet, R; Chauvergne, J; De Mascarel, A; Durand, M; Hoerni, B; Hoerni-Simon, G; Lagarde, C; Meugé, C; Richaud, P | 1 |
| Duménil, D; Frindel, E; Sainteny, F | 1 |
| Albahary, C; Amiel, JL; Belpomme, D; de Vassal, F; Depierre, R; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Pouillart, P; Schwarzenberg, L | 1 |
| Gadner, H; Harbott, J; Henze, G; Lampert, F; Ludwig, WD; Müller-Weihrich, S; Niemeyer, CM; Reiter, A; Ritter, J; Schrappe, M | 1 |
| Carde, P; de Pauw, B; de Wolf-Peeters, C; Kluin-Nelemans, JC; Meerwaldt, JH; Monconduit, M; Somers, R; Tanguy, A; Thomas, J; van Glabbeke, M | 1 |
| Bello, JL; Feliu, J; García de Bustos, J; Losada, G; Manso, F; Quevedo, E | 1 |
| Burgers, JM; Carde, P; de Wolf-Peeters, C; Duez, N; Glabbeke, MV; Meerwaldt, JH; Monconduit, M; Sizoo, W; Somers, R; Thomas, J | 1 |
| Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Goebel, U; Graubner, U; Haas, RJ; Janka-Schaub, GE; Juergens, H; Spaar, HJ; Winkler, K | 1 |
| Belasco, JB; Luery, N; Scher, C | 1 |
| Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Anders, CU; Donhuijsen, K; Günzel, K; Höffken, K; Kath, R; Nowrousian, MR; Sack, H; Schmidt, CG | 1 |
| Archimbaud, E; Berger, F; Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gentilhomme, O; Guyotat, D; Magaud, JP | 1 |
| Civatte, J; Flageul, B; Iskandar, MJ; Maillet, M; Moulonguet, I; Perrin, P; Verola, O | 1 |
| Ayed, K; Ben Khalifa, H; Ben Salah, N; Ben-Ayed, F; Bouguerra, A; Boussene, H; Halphen, M; Jaafoura, H; Mourali, N; Najjar, T | 1 |
| Boyett, J; Buchanan, GR; Murphy, SB; Winick, N; Yu, A | 1 |
| Forman, SJ; Levitt, LJ; Linker, CA; O'Donnell, M; Ries, CA | 1 |
| Abromowitch, M; Dahl, GV; Dodge, RK; Hustu, HO; Kalwinsky, DK; Look, AT; Mirro, J; Murphy, SB; Ochs, J; Rivera, GK | 1 |
| Castel, V; Esquembre, C; Ferris, J; Verdeguer, A | 1 |
| Bernard, JF; Boivin, P; Brousse, N; Chastang, C; Desaint, B; Gaulard, P; Herrera, A; Renoux, M; Solal-Celigny, P | 1 |
| Burgers, JM; Carde, P; Cosset, JM; Somers, R; Tubiana, M; Van Glabbeke, M | 1 |
| Amylon, M; Boyett, JM; Buchanan, G; Camitta, B; Crist, WM; Kalwinsky, D; Ochs, J; Rivera, GK; Vietti, TJ | 1 |
| Barbieri, E; Emiliani, E; Gherlinzoni, F; Lauria, F; Mazza, P; Tabanelli, M; Tura, S; Zinzani, PL | 1 |
| Divine, M; Farcet, JP; Gaulard, P; Haioun, C; Jouault, H; Kuentz, M; Reyes, F | 1 |
| Chojnowski, K; Dmochowska, M; Krykowski, E; Olszańska-Skorek, T; Robak, T; Urbańska-Ryś, H | 1 |
| Amiel, JL; Carde, P; Cosset, JM; Habrand, JL; Hayat, M; Henry-Amar, M; Ozanne, F; Tubiana, M | 1 |
| Donner, L; Klener, P | 1 |
| Archimbaud, E; Blanc, M; Bryon, PA; Coiffier, B; Felman, P; Ffrench, M; Fière, D; Guyotat, D; Rebattu, P; Vuvan, H | 1 |
| Burgers, JM; Quasim, MM; Somers, R; van Glabbekke, M | 1 |
| Burgers, JM; Dekker, AW; Kazem, I; Kroese, WF; Qasim, MM; Sizoo, W; Somers, R; van Peperzeel, HA; Wagener, DJ | 1 |
| Anderson, J; Bennett, JM; Berard, CW; Brodovsky, HS; Glick, JH; Merrill, JM; Neiman, RS; O'Connell, MJ | 1 |
| Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Veronesi, A; Volpe, R | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Kalwinsky, DK; Murphy, SB; Rivera, G; Stagner, S; Wood, A | 1 |
| Aur, RJ; Avery, TL; Bowman, WP; Dahl, GV; Murphy, SB; Rivera, G; Simone, JV | 1 |
| Babare, R; Carbone, A; Lazzarini, R; Merola, MC; Monfardini, S; Talamini, R; Tirelli, U; Zagonel, V | 1 |
| Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
| Bastion, Y; Brice, P; Coiffier, B; Espinouse, D; Gisselbrecht, C; Haioun, C; Marolleau, JP; Reyes, F; Salles, G; Sonet, A | 1 |
| Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M | 1 |
| Furuta, H; Miyabe, K; Miyaguchi, M; Sakai, S; Takeda, J; Uozumi, N | 1 |
| Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W | 1 |
| Katou, H; Kuwabara, H; Miyaguchi, M; Sakai, S; Sakamoto, H; Yamauchi, A | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D | 1 |
| Gururangan, S; Horner, M; Marina, NM; Rodman, JH | 1 |
| Bosly, A; Brice, P; Brousse, N; Haioun, C; Lepage, E; Leporrier, M; Parlier, Y; Peuchmaur, M; Reyes, F; Solal-Celigny, P | 1 |
| Gerrits, WB; Haak, HL; Kerkhofs, H; Wijermans, PW | 1 |
| Büchner, T; Freund, M; Heil, G; Hiddemann, W; Hoelzer, D; Löffler, H; Ludwig, WD; Maschmeyer, G; Thiel, E; Völkers, B | 1 |
| Andrea, M; Aranega, V; Brandalise, S; Odone, V; Pereira, W; Zanichelli, M | 1 |
| Arnold, R; Aul, C; Büchner, T; Diedrich, H; Faak, T; Fabry, U; Fischer, K; Fonatsch, C; Freund, M; Fuhr, HG; Gassmann, W; Gökbuget, N; Gramatzki, M; Heil, G; Heinze, B; Heyll, A; Hiddemann, W; Hoelzer, D; Hossfeld, D; Ittel, TH; Koch, P; Kolbe, K; Kuse, R; Löffler, H; Ludwig, WD; Maschmeyer, G; Messerer, D; Metzner, B; Rieder, H; Schadeck-Gressel, C; Strohscheer, I; Thiel, E; Uberla, K; Völkers, B; Weiss, A | 1 |
| Audouin, J; Bernadou, A; Chauvenet, L; Ciaudo, M; Favier, R; Horellou, MH; Rossert, J; Samama, M | 1 |
| Benaim, E; Crist, WM; Hudson, MM; Liu, Q; Pui, CH; Ribeiro, RC; Rivera, GK | 1 |
| Bosq, J; Carde, P; Cosset, JM; Decaudin, D; Dhermain, F; Girinsky, T; Hayat, M; Juliéron, M; Koscielny, S; Munck, JN | 1 |
| Bijnens, L; Bron, D; Carde, P; Cosset, JM; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Somers, R; Teodorovic, I; Thomas, J | 1 |
| Cardenas-Cardos, R; Gómez-Martínez, R; Leal-Leal, C; Meza-Coria, C; Navarro-Alegría, I; Rivera-Luna, R; Vega-Vega, L | 1 |
| Bastion, Y; Blanc, M; Blay, JY; Bordessoule, D; Brice, P; Brière, J; Coiffier, B; Deconinck, E; Divine, M; Dumontet, C; Lederlin, P; Salles, B; Sebban, C; Tilly, H | 1 |
| McNeil, C | 1 |
| Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Doyen, C; Gabarre, J; Haïoun, C; Lepage, E; Pignon, B; Rossi, JF; Solal-Céligny, P; Tendler, CL; Tertian, G | 1 |
| Cole, BF; Gelber, RD; Gisselbrecht, C; Goldhirsch, A; Lepage, E; Reyes, F; Sebban, C; Solal-Céligny, P; Sugano, D; Tendler, C | 1 |
| Belhadj, K; Brice, P; Brousse, N; Chèze, S; Coiffier, B; Decaudin, D; Harousseau, JL; Lepage, E; Michaux, L; Solal-Céligny, P; Tilly, H | 1 |
| Belanger, C; Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Haioun, C; Janvier, M; Neidhardt-Bérard, EM; Péaud, PY; Pico, JL; Solal-Celigny, P; Tilly, H | 1 |
| Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H | 1 |
| Anastasopoulou, A; Bron, D; Carbone, A; Carde, P; Kluin-Nelemans, HC; Maes, B; Musson, H; Noordijk, EM; Roozendaal, KJ; Teodorovic, I; Thomas, J; Zagonel, V | 1 |
| di Gennaro, G; Nasti, G; Schioppa, O; Spina, M; Talamini, R; Tirelli, U; Vaccher, E; Vultaggio, G | 1 |
| André, F; Bayssas, M; Caillot, D; Canal, P; Casasnovas, RO; Chauffert, B; Fenaux, P; Genne, P; Grandjean, M; Guy, H; Mannone, L; Moreau, D; Solary, E; Wolf, JE; Wotawa, A | 1 |
| Bibeau, F; Cebotaru, C; El Weshi, A; Fadel, C; Fenaux, P; Frayfer, J; Laribi, K; Ribrag, V | 1 |
| Fezoui, H; Genet, P; Lionnet, F; Louvel, D; Pulik, M; Touahri, T | 1 |
| Barbui, T; Bassan, R; Carter, M; Casula, P; Di Bona, E; Fabris, P; Lambertenghi-Deliliers, G; Lerede, T; Lister, TA; Morandi, S; Pogliani, E; Rambaldi, A; Rohatiner, AZ; Rossi, G | 1 |
| Ericsson, SM; Glimelius, BL; Larsson, RL; Nygren, HP; Sundström, C | 1 |
| Deelman, BG; Kamps, WA; Kingma, A; Mooyaart, EL; Van Dommelen, RI; Wilmink, JT | 1 |
| Crocci, AJ; Lopes, LF; Minicucci, EM | 1 |
| Fievet, MH; Gabarre, J; Junot, H; Malliti, M; Taright, N; Thuillier, A; Vernant, JP | 1 |
| Baars, JW; Carde, P; de Wolf-Peeters, C; Kluin-Nelemans, JC; Moser, EC; Noordijk, EM; Raemaekers, JM; Teodorovic, I; Tirelli, U; van Glabbeke, M | 1 |
| Feng, FY; Gu, DZ; Hu, Y; Shi, YK; Wang, QL; Zhou, LQ | 1 |
| Enschede, SH; Gregory, SA; Porter, C; Venugopal, P | 1 |
| Belanger, C; Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Doyen, C; Feugier, P; Haioun, C; Mounier, N; Salles, G; Sebban, C; Tilly, H | 1 |
| Abella, E; Bethencourt, C; Brunet, S; Debén, G; del Potro, E; Feliu, E; Hernández-Rivas, JM; López, R; Morgades, M; Novo, A; Oriol, A; Ortega-Rivas, F; Ortín, X; Ribera, JM; Sancho, JM; Sanz, MA; Tormo, M; Xicoy, B | 1 |
| Morrison, VA | 1 |
| Brousse, N; Canioni, D; Foussard, C; Keuppens, M; Lamy, T; Morchhauser, F; Mounier, N; Rousselet, MC; Salles, G; Sonet, A; Xerri, L | 1 |
| Aldoss, IT; Armitage, JO; Bierman, PJ; Bociek, RG; Chan, WC; Fu, K; Vose, JM; Weisenburger, DD | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| Ma, X; Ren, C; Sheng, Z; Wang, B; Xia, B; Zhang, W | 1 |
| Audhuy, B; Bachy, E; Belhadj, K; Brice, P; Brousse, N; Cartron, G; Delwail, V; Fermé, C; Feugier, P; Foussard, C; Houot, R; Le Gouill, S; Lefort, S; Maisonneuve, H; Morschhauser, F; Salles, G; Sebban, C; Sonet, A | 1 |
| Ahmad, AK; Azodi, M; Hui, P; Litkouhi, B; McCarthy, S; Ratner, E; Rutherford, T; Schwartz, PE; Xu, ML | 1 |
6 review(s) available for prednisone and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prognostic factors in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Prednisone; Prognosis; Teniposide; Vincristine | 1986 |
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Teniposide; Treatment Outcome; Vinblastine | 2004 |
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Longitudinal Studies; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prevalence; Prognosis; Recombinant Proteins; Survival Rate; Teniposide; Vincristine | 2007 |
Adult Burkitt lymphoma: advances in diagnosis and treatment.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Genes, myc; Humans; Ifosfamide; Leucovorin; Methotrexate; Practice Guidelines as Topic; Prednisone; Prognosis; Rituximab; Stem Cell Transplantation; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2008 |
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2013 |
37 trial(s) available for prednisone and arginine
| Article | Year |
|---|---|
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Middle Aged; Prednisone; Vincristine | 1994 |
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Humans; Mammography; Mastectomy; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Ultrasonography; Vincristine | 1994 |
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine | 1998 |
Preservation of growth hormone secretion in response to growth hormone-releasing peptide-2 during prednisone therapy.
Topics: Adult; Anti-Inflammatory Agents; Arginine; Drug Administration Schedule; Human Growth Hormone; Humans; Male; Oligopeptides; Prednisone; Somatostatin; Time Factors | 1999 |
[O.E.R.T.C. study on the treatment of non-Hodgkin's lymphomas: origin-aims-means (author's transl)].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Prednisone; Teniposide | 1977 |
[Induction chemotherapy of non-Hodgkin malignant lymphomas. Results of a controlled trial comparing two quadruple associations (author's transl)].
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Teniposide; Vincristine | 1978 |
Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high-grade non-Hodgkin's lymphoma (NHL): the 1980-1985 EORTC trial. The EORTC Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Survival Rate; Teniposide; Vincristine | 1991 |
Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Teniposide; Whole-Body Irradiation | 1991 |
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Survival Rate; Teniposide; Testicular Neoplasms; Vincristine | 1991 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Germany, West; Humans; Infant; Infant, Newborn; Leukocyte Count; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Risk; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
Prognostic factors in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Prednisone; Prognosis; Teniposide; Vincristine | 1986 |
Report on the EORTC lymphoma trial 20751.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Europe; Humans; Lymphoma; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Teniposide; Vincristine | 1983 |
Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas.
Topics: Adult; Altretamine; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hematopoietic System; Humans; Lymphoma; Male; Middle Aged; Podophyllotoxin; Prednisone; Prospective Studies; Random Allocation; Teniposide | 1982 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine | 1995 |
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Regression Analysis; Survival Rate; Teniposide | 1993 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Teniposide; Vincristine | 1993 |
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Mediastinum; Mercaptopurine; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Teniposide; Vincristine | 1993 |
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Drug Administration Schedule; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Teniposide; Vincristine | 1993 |
Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Patient Compliance; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Radiotherapy; Teniposide; Time Factors | 1996 |
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Risk Factors; Teniposide; Treatment Outcome; Vincristine | 1997 |
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Immunophenotyping; Infant; Life Tables; Male; Mercaptopurine; Methotrexate; Neprilysin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Risk Factors; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 1997 |
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Teniposide | 1997 |
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prognosis; Recombinant Proteins; Survival Analysis; Teniposide | 1998 |
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferons; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Survival Analysis; Teniposide; Vidarabine | 1999 |
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 2000 |
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2001 |
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Teniposide; Treatment Outcome; Vincristine | 2001 |
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cinchona Alkaloids; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrocardiography; Female; Heart; Humans; Leukopenia; Lymphoproliferative Disorders; Male; Middle Aged; Prednisone; Recurrence; Teniposide | 2000 |
Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Proteins; Remission Induction; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de
Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; France; Humans; Interferon Type I; Lymphoma, Follicular; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Recombinant Proteins; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2006 |
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Severity of Illness Index; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2007 |
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon-alpha; Lymphoma, Follicular; Macrophages; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Rituximab; Survival Rate; Teniposide; Treatment Outcome | 2008 |
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Survival Rate; Teniposide; Time Factors; Young Adult | 2013 |
71 other study(ies) available for prednisone and arginine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.
Topics: Adult; Age Factors; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Carboxypeptidases; Chronic Disease; Edetic Acid; Female; Hippurates; Humans; Lung Diseases; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Prednisone; Sarcoidosis; Sex Factors; Teprotide | 1975 |
Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
Topics: Adult; Arginine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Immunosuppression Therapy; Kinetics; Male; Prednisone; Radioimmunoassay; Reference Values; Time Factors | 1992 |
Effect of corticoid therapy on growth hormone secretion.
Topics: Arginine; Child; Child, Preschool; Female; Growth; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone | 1991 |
Hypopituitarism and ketotic hypoglycemia.
Topics: Acetone; Acidosis; Arginine; Body Height; Body Weight; Child; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Growth; Growth Hormone; Humans; Hypoglycemia; Hypopituitarism; Insulin; Iodine Isotopes; Metyrapone; Pituitary-Adrenal Function Tests; Prednisone; Seizures; Thyroid Function Tests; Thyroid Hormones | 1971 |
Kinins and anti-inflammatory steroids.
Topics: Animals; Arginine; Betamethasone; Dexamethasone; Esters; Fibrinolysin; gamma-Globulins; Glass; Glucocorticoids; Guinea Pigs; Humans; Hydrocortisone; In Vitro Techniques; Kallikreins; Kinins; Pancreas; Plasma; Prednisolone; Prednisone; Rats; Rheumatoid Factor; Saliva | 1968 |
Intermittent steroid therapy. Its effect on hypothalamic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Arginine; Blood Glucose; Child; Circadian Rhythm; Colitis, Ulcerative; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Metyrapone; Nephrotic Syndrome; Pituitary-Adrenal Function Tests; Prednisone; Radioimmunoassay | 1968 |
[Current views on the therapy of hepatic coma].
Topics: Acute Kidney Injury; Adolescent; Amino Acids; Ammonia; Anti-Bacterial Agents; Arginine; Aspartic Acid; Coenzyme A; Diet Therapy; Exchange Transfusion, Whole Blood; Glutamates; Hepatic Encephalopathy; Humans; Malates; Male; NAD; Ornithine; Prednisone; Prognosis; Renal Dialysis; Thiamine Pyrophosphate; Thioctic Acid; Vasopressins | 1970 |
Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone.
Topics: Adolescent; Adult; Arginine; Blood; Carcinoma, Small Cell; Cyclophosphamide; Humans; Leukemia, Lymphoid; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Osmolar Concentration; Peripheral Nervous System Diseases; Prednisone; Radioimmunoassay; Sodium; Urine; Vasopressins; Vincristine | 1973 |
Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Topics: Adolescent; Adult; Analysis of Variance; Arginine; Blood Glucose; Body Mass Index; Carrier Proteins; Child; Circadian Rhythm; Female; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Immunosuppression Therapy; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kidney Transplantation; Male; Prednisone; Somatomedins | 1993 |
[The effect of long-term cyclosporin and prednisone therapy on insulin secretory reserve].
Topics: Adult; Analysis of Variance; Arginine; Blood Glucose; Cyclosporine; Female; Humans; Insulin; Insulin Secretion; Male; Prednisone; Time Factors | 1994 |
Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.
Topics: Adult; Arginine; Arthritis; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Psoriasis; Transplantation, Homologous | 1994 |
Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis.
Topics: Animals; Anti-Inflammatory Agents; Arginine; Bacterial Translocation; Dehydroepiandrosterone; Evaluation Studies as Topic; Female; Glucocorticoids; Glutamine; Immune Tolerance; Mice; Mice, Inbred BALB C; Prednisone; Prospective Studies; Random Allocation; Sepsis | 1997 |
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis; Butyrates; Cyclophosphamide; Doxorubicin; Drug Synergism; Enzyme Induction; Epstein-Barr Virus Infections; Fatal Outcome; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Necrosis; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thymidine Kinase; Tumor Cells, Cultured; Vincristine; Viral Nonstructural Proteins | 1998 |
Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.
Topics: Animals; Arginine; Behavior, Animal; Butyrates; Disease Models, Animal; Drug Therapy, Combination; Female; Gene Expression Profiling; Gene Expression Regulation; Heart; Mice; Mice, Inbred mdx; Muscles; Muscular Dystrophy, Duchenne; Prednisone; RNA, Messenger; Time Factors; Utrophin | 2010 |
Hypereosinophilic syndrome with cardiac involvement in a pregnant patient with multiple sclerosis.
Topics: Adult; Anticoagulants; Arginine; Drug Substitution; Female; Glucocorticoids; Heparin; Humans; Hypereosinophilic Syndrome; Multiple Sclerosis; Pipecolic Acids; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression.
Topics: Adult; Advanced Oxidation Protein Products; Arginine; Catalase; Female; Healthy Volunteers; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nitrates; Nitrites; Oxidative Stress; Prednisone; Sex Factors; Sulfhydryl Compounds; Tacrolimus; Thiobarbituric Acid Reactive Substances | 2014 |
Effects of cluster headache preventatives on mouse hypothalamic transcriptional homeostasis.
Topics: Amitriptyline; Animals; Arginine; Arginine Vasopressin; CLOCK Proteins; Cluster Headache; Homeostasis; Hypothalamus; Lithium; Mice; Oxytocin; Prednisone; Verapamil | 2022 |
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine | 1975 |
Childhood cancer: the improving prognosis.
Topics: Asparaginase; Child; Cyclophosphamide; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Osteosarcoma; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Rhabdomyosarcoma; Teniposide; Thioguanine; Vincristine; Wilms Tumor | 1976 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide | 1977 |
Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Colony-Forming Units Assay; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Hematopoietic Stem Cells; Leukocyte Count; Lymphoma; Male; Methylprednisolone; Mice; Mice, Inbred CBA; Models, Biological; Prednisone; Teniposide | 1979 |
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Seeding; Podophyllotoxin; Prednisone; Remission, Spontaneous; Teniposide | 1975 |
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Prednisone; Prognosis; Recurrence; Remission Induction; Teniposide; Vincristine | 1992 |
[Plasma cell leukemia: our experience in 4 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Plasma Cell; Male; Melphalan; Middle Aged; Prednisolone; Prednisone; Remission Induction; Teniposide | 1991 |
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine | 1990 |
[Chemotherapy of nonendemic Burkitt's lymphoma].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Prednisone; Teniposide | 1990 |
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Teniposide; Vincristine | 1986 |
[Ki-1 large cell lymphoma with secondary xanthomatous infiltration of the lesions by chemotherapy].
Topics: Aged; Aged, 80 and over; Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Cyclophosphamide; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma; Male; Neck; Prednisone; Skin Neoplasms; Teniposide; Xanthomatosis | 1989 |
Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoproliferative Small Intestinal Disease; Laparotomy; Male; Neoplasm Staging; Prednisone; Prospective Studies; Teniposide; Tunisia | 1989 |
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunorubicin; Humans; Pentostatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Ribonucleosides; T-Lymphocytes; Teniposide; Vincristine | 1988 |
Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Topics: Adult; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Vincristine | 1987 |
Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Lymphoid; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Teniposide; Vincristine | 1987 |
[Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Prognosis; Risk Factors; Teniposide; Vincristine | 1987 |
Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Teniposide | 1987 |
Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Infant; Leukemia, Lymphoid; Male; Prednisone; Teniposide; Vincristine | 1986 |
Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Vincristine | 1987 |
Failure of combination chemotherapy of advanced follicular (low-grade) non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Time Factors; Vincristine | 1987 |
[Use of lomustine, teniposide, procarbazine and prednisone (LTPP) in the treatment of terminal-state Hodgkin's disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednisone; Procarbazine; Teniposide; Terminal Care | 1986 |
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Teniposide; Time Factors | 1985 |
Therapy of non-Hodgkin's lymphomas in relapse.
Topics: Cyclophosphamide; Drug Therapy, Combination; Humans; Imidazoles; Lymphoma; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Splenectomy; Teniposide; Vincristine | 1980 |
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma; Male; Prednisolone; Prednisone; Prognosis; Teniposide; Thioguanine; Vincristine | 1983 |
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Europe; Female; Hodgkin Disease; Humans; Leukopenia; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Radiotherapy; Recurrence; Teniposide; Vincristine | 1983 |
Primary lymphoblastic lymphoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Teniposide; Vincristine | 1982 |
VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Recurrence; Teniposide; Vincristine | 1982 |
VM26 therapy in children with drug-refractory lymphocytic leukemia.
Topics: Child; Cytarabine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Podophyllotoxin; Prednisone; Teniposide; Vincristine | 1982 |
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
Topics: Age Factors; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Infection Control; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Safety; Teniposide; Treatment Outcome; Vincristine | 1994 |
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Graft Rejection; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma, Follicular; Melphalan; Middle Aged; Pancytopenia; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
[Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Methotrexate; Prednisone; Teniposide; Vincristine | 1993 |
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Leukemia, Myelomonocytic, Acute; Luteinizing Hormone; Melphalan; Menotropins; Ovulation Induction; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy, Multiple; Primary Ovarian Insufficiency; Remission Induction; Teniposide; Thioguanine; Vincristine | 1993 |
[Evaluation of the method of treating non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Teniposide; Vincristine | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1994 |
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cytarabine; Daunorubicin; Female; Humans; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Teniposide; Vincristine | 1994 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Leukemic Infiltration; Male; Meninges; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stomatitis; Survival Analysis; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1996 |
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Peripheral; Methotrexate; Mitoguazone; Prednisone; Teniposide; Verapamil; Vincristine; Vindesine | 1995 |
Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Female; Growth Disorders; Humans; Hydrocortisone; Leukemic Infiltration; Life Tables; Male; Meninges; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Survival Rate; Teniposide; Testis; Time Factors; Treatment Outcome; Vincristine | 1996 |
Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Teniposide; Vincristine | 1998 |
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Making; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Quality-Adjusted Life Years; Recombinant Proteins; Survival Analysis; Teniposide | 1998 |
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Teniposide | 1999 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2001 |
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Interferon-alpha; Lymphoma, Follicular; Opportunistic Infections; Prednisone; Salvage Therapy; Teniposide; Toxoplasmosis, Cerebral; Vidarabine | 2002 |
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Idarubicin; Life Tables; Male; Melphalan; Mercaptopurine; Middle Aged; Neoplasm Proteins; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2000 |
Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunophenotyping; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Methotrexate; Mitotic Index; Neoplasm Staging; Prednisone; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2002 |
No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Attention; Child, Preschool; Cognition Disorders; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Learning Disabilities; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Netherlands; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Survivors; Teniposide; Treatment Outcome; Vincristine | 2002 |
Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dental Enamel Hypoplasia; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Teniposide; Tooth Abnormalities; Tooth Diseases; Tooth Eruption; Tooth Root; Vincristine | 2003 |
[Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
Topics: Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Drug Hypersensitivity; Female; Hospitalization; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Retrospective Studies; Rituximab; Teniposide; Thrombocytopenia; Vincristine; Vomiting | 2003 |
[Primary central nervous system lymphoma: a report of 28 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Teniposide | 2004 |
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Female; Genital Neoplasms, Female; Gynecologic Surgical Procedures; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Survival Analysis; Teniposide; Vincristine; Young Adult | 2014 |